Recovery Over Time and Prognostic Factors in Treated Patients with Post-Infectious Olfactory Dysfunction: A Retrospective Study

被引:13
|
作者
Ogawa, Takao [1 ]
Nakamura, Keigo [1 ]
Yamamoto, Sayuri [1 ]
Tojima, Ichiro [1 ]
Shimizu, Takeshi [1 ]
机构
[1] Shiga Univ Med Sci, Dept Otorhinolaryngol, Otsu, Shiga 5202192, Japan
关键词
post-infectious; olfactory dysfunction; recovery; prognostic factor; Toki-shakuyaku-san; zinc; NERVE GROWTH-FACTOR; DOUBLE-BLIND; VITAMIN-A; FOLLOW-UP; BIOPSIES;
D O I
10.1177/0003489420922563
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objectives: The aims of the present study were to clarify the time-course of olfactory recovery and the prognostic factors in PIOD patients treated with Toki-shakuyaku-san (TSS). Methods: A retrospective cohort study of patients with PIOD was conducted by reviewing patients' medical records. This study included patients who received TSS or a combination of TSS and zinc sulfate. Olfactory function was examined by T&T olfactometer at each 3-monthly follow-up visit. Patients with normal and mild olfactory dysfunction were excluded. Gender, age, treatment, duration of disease until the first visit and olfactory function scores of the T&T olfactometer at the first visit were analyzed as candidate clinical predictors of recovery. Results: A total of 82 PIOD patients with ages ranging from 16 to 79 years were included. The mean duration of follow-up was 14.5 months (range 3-45 months). The number of patients with olfactory recovery increased for 24 months and the cumulative recovery rate was 77.3%. In about 60% of patients, olfactory recovery occurred within 6 months. Multivariate analysis showed that younger age (<65 years) and residual olfactory function were significantly associated with good olfactory recovery. Conclusions: We revealed recovery rates over time in patients with PIOD. The recovery of olfactory function often occurred during the early period (<= 6 months). However, the number of patients with olfactory recovery increased for a long-term of 24 months after the first visit. Residual olfactory function and younger age were prognostic factors exactly. TSS may be a useful therapeutic agent for patients with PIOD. We believe that these results provide important information that is useful for counseling patients with PIOD.
引用
收藏
页码:977 / 982
页数:6
相关论文
共 50 条
  • [11] Prognostic factors of patients with advanced lung cancer treated with anlotinib: a retrospective cohort study
    Fan, Bijun
    Tan, Xiaoming
    Lou, Yueyan
    Zheng, Yu
    Zhang, Liyan
    Wu, Xueling
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (10)
  • [12] The Prognostic Value of Olfactory Dysfunction in Patients with COVID-19: The COVIDORA Study
    Hamel, Anne-Laure
    Delbos, Leo
    Natella, Pierre-Andre
    Radulesco, Thomas
    Alexandru, Mihaela
    Bartaire, Emmanuel
    Bartier, Sophie
    Benoite, Gonda
    Bequignon, Emilie
    Castillo, Laurent
    Canoui-Poitrine, Florence
    Carsuzaa, Florent
    Corre, Alain
    Coste, Andre
    Couloigner, Vincent
    Daveau, Clementine
    De Boissieu, Paul
    De Bonnecaze, Guillaume
    De Gabory, Ludovic
    Debry, Christian
    Deraedt, Simon
    Dufour, Xavier
    El Bakkouri, Wissame
    Gilain, Laurent
    Hans, Stephane
    Hautefort, Charlotte
    Hermann, Ruben
    Jankowski, Roger
    La Croix, Candice
    Lecanu, Jean-Baptiste
    Malard, Olivier
    Michel, Justin
    Nguyen, Yann
    Nevoux, Jerome
    Papon, Jean-Francois
    Patron, Vincent
    Prigent, Marine
    Pruliere-Escabasse, Virginie
    Renaud, Marion
    Rumeau, Cecile
    Salmon, Dominique
    Saroul, Nicolas
    Serrano, Elie
    Nhung Tran Khai, Christine
    Tringali, Stephane
    Truy, Eric
    Vandersteen, Clair
    Verillaud, Benjamin
    Veil, Raphael
    Fieux, Maxime
    LIFE-BASEL, 2024, 14 (03):
  • [13] Radiotherapy and prognostic factors for thymoma: A retrospective study of 175 patients
    Zhu, GP
    He, SQ
    Fu, XL
    Jiang, GL
    Liu, TF
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (04): : 1113 - 1119
  • [14] Prognostic factors for patients treated for a recurrent FIGO stage III ovarian cancer: A retrospective study of 108 cases
    Classe, J. M.
    Jaffre, I.
    Frenel, J. S.
    Bordes, V.
    Dejode, M.
    Dravet, F.
    Ferron, G.
    Marchal, F.
    Rigaud, D. Berton
    Loussouarn, D.
    Campion, L.
    EJSO, 2011, 37 (11): : 971 - 977
  • [15] Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction
    Saussez, Sven
    Sharma, Shilpee
    Thiriad, Anais
    Olislagers, Veronique
    Duc, Ines Vu
    Le Bon, Serge-D
    Khalife, Mohamad
    Hans, Stephane
    De Riu, Giacomo
    Hopkins, Claire
    Lechien, Jerome R.
    Vaira, Luigi A.
    Marchant, Arnaud
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (11) : 3702 - 3711
  • [16] Prevalence and recovery time of olfactory and gustatory dysfunction in hospitalized patients with COVID-19 in Wuhan, China
    Lv, Hao
    Zhang, Wei
    Zhu, Zhanyong
    Xiong, Qiutang
    Xiang, Rong
    Wang, Yingying
    Shi, Wendan
    Deng, Zhifeng
    Xu, Yu
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 100 : 507 - 512
  • [17] Prognostic factors in carpal tunnel syndrome treated with 5% dextrose perineural injection: A retrospective study
    Ho, Tsung-Yen
    Chen, Si-Ru
    Li, Tsung-Ying
    Li, Chun-Yi
    Lam, King Hei Stanley
    Chen, Liang-Cheng
    Wu, Yung-Tsan
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (09): : 1960 - 1965
  • [18] Clinical features as potential prognostic factors in patients treated with nivolumab for highly pretreated metastatic gastric cancer: a multicenter retrospective study
    Sano, Akihiko
    Sohda, Makoto
    Nakazawa, Nobuhiro
    Ubukata, Yasunari
    Kuriyama, Kengo
    Kimura, Akiharu
    Kogure, Norimichi
    Hosaka, Hisashi
    Naganuma, Atsushi
    Sekiguchi, Masanori
    Saito, Kana
    Ogata, Kyoichi
    Sakai, Makoto
    Ogawa, Hiroomi
    Shirabe, Ken
    Saeki, Hiroshi
    BMC CANCER, 2022, 22 (01)
  • [19] A Retrospective Study of Patients with GABABR Encephalitis: Therapy, Disease Activity and Prognostic Factors
    Wen, Xiangchuan
    Wang, Baojie
    Wang, Chunjuan
    Han, Chenglin
    Guo, Shougang
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 99 - 110
  • [20] Kampo Medicine Promotes Early Recovery From Coronavirus Disease 2019-Related Olfactory Dysfunction: A Retrospective Observational Study
    Ono, Rie
    Arita, Ryutaro
    Takayama, Shin
    Kikuchi, Akiko
    Ohsawa, Minoru
    Saito, Natsumi
    Suzuki, Satoko
    Ishii, Tadashi
    FRONTIERS IN PHARMACOLOGY, 2022, 13